Children infected with Ebola may require different treatment regimens

Tuesday, Aug 12, 2014 @ 5:00pm by BioPrepWatch Reports

Ebola
Read More »

ECBC demonstrates latest technologies at showcase

Wednesday, Aug 13, 2014 @ 1:00pm by BioPrepWatch Reports

The Edgewood Chemical Biological Center (ECBC) showed off its latest technologies on August 5-6 during the first Team CBRNE Capabilities Showcase.
Read More »

MSF says WHO Ebola declaration must translate to action

Wednesday, Aug 13, 2014 @ 1:30pm by BioPrepWatch Reports

Médecins Sans Frontières (MSF), an international medical aid organization, said on Friday that the world must take action against the Ebola outbreak in West Africa.
Read More »

CDC updates ebola information for U.S. clinicians

Wednesday, Aug 13, 2014 @ 2:00pm by BioPrepWatch Reports

The Centers for Disease Control and Prevention provided an update to clinicians in U.S. hospitals and health clinics on Sunday on how to recognize and treat the ebola virus.
Read More »

Secretary Johnson addresses ABA

Wednesday, Aug 13, 2014 @ 2:30pm by BioPrepWatch Reports

Jeh Johnson
Read More »

Delaware court orders SIGA to pay damages to PharmAthene

Wednesday, Aug 13, 2014 @ 3:00pm by BioPrepWatch Reports

PharmAthene, Inc., a medical countermeasure developer, announced on Sunday that the Delaware Court of Chancery ordered SIGA Technologies, Inc., to pay lump sum expectation damages for lost profits of SIGA's smallpox antiviral.
Read More »

U.N. Meeting of Experts concludes

Wednesday, Aug 13, 2014 @ 4:00pm by BioPrepWatch Reports

The United Nations' 2014 Biological Weapons Convention (BWC) Meeting of Experts concluded on Friday in Geneva.
Read More »

California health authorities find ebola does not pose significant threat to state

Wednesday, Aug 13, 2014 @ 4:30pm by BioPrepWatch Reports

Ron Chapman
Read More »

USAID commits more than $12 billion to West African Ebola response

Thursday, Aug 14, 2014 @ 1:00pm by BioPrepWatch Reports

The U.S. Agency for International Development (USAID) announced last week that it would contribute more than $12 million in additional funding to help stop the West African Ebola outbreak.
Read More »

G-CON Manufacturing launches disease containment system

Thursday, Aug 14, 2014 @ 1:30pm by BioPrepWatch Reports

 
Read More »

EOUSA, USAO seek emergency management specialist

Thursday, Aug 14, 2014 @ 2:00pm by BioPrepWatch Reports

The Executive Office for U.S. Attorneys (EOUSA) and the U.S. Attorneys' Office (USAO) within the Department of Justice are looking to hire an emergency management specialist.
Read More »

WHO bioethics panel approves use of experimental ebola treatments

Thursday, Aug 14, 2014 @ 2:30pm by BioPrepWatch Reports

A panel of bioethicists and other experts convened by the World Health Organization said on Monday that in light the ongoing ebola outbreak in West Africa, it is ethical to use experimental treatments.
Read More »

Microbiologist receives DoD contract to research tularemia vaccine

Thursday, Aug 14, 2014 @ 3:00pm by BioPrepWatch Reports

Karl Klose
Read More »

NAMRU-6 Head of Virology Bausch plays major role in response to Ebola outbreak

Thursday, Aug 14, 2014 @ 3:30pm by BioPrepWatch Reports

Daniel Bausch
Read More »

Osceola County looking to hire emergency management director

Thursday, Aug 14, 2014 @ 4:00pm by BioPrepWatch Reports

Osceola County, Fla., is seeking to hire an emergency management director.
Read More »

DoD chemical and biological defense head discusses neutralization system

Thursday, Aug 14, 2014 @ 4:30pm by BioPrepWatch Reports

Carmen Spencer
Read More »

Corgenix, VHFC begin development of Ebola rapid diagnostic test kit

Friday, Aug 15, 2014 @ 1:00pm by BioPrepWatch Reports

Corgenix Medical Corporation, a diagnostic kit developer, announced on Monday that it joined the Viral Hemorrhagic Fever Consortium (VHFC) to begin work on the development of an Ebola rapid diagnostic test kit.
Read More »

NIAID exercises additional options for hemorrhagic fever treatment

Friday, Aug 15, 2014 @ 2:00pm by BioPrepWatch Reports

BioCryst Pharmaceuticals, Inc., announced on Wednesday that the National Institute of Allergy and Infectious Diseases (NIAID) exercised additional options to conduct Phase I clinical trials of an intramuscular formulation of its hemorrhagic fever disease treatment BCX4430.
Read More »

PositiveID to exhibit Firefly Dx at military symposium

Friday, Aug 15, 2014 @ 2:30pm by BioPrepWatch Reports

Biological detection and diagnostic company PositiveID Corp. announced on Wednesday that it will exhibit at the 2014 Military Health System Research Symposium (MHSRS) Conference in Fort Lauderdale, Fla.
Read More »

NIH awards $14.5 million grant to OMRF for anthrax studies

Friday, Aug 15, 2014 @ 3:00pm by BioPrepWatch Reports

The Oklahoma Medical Research Foundation (OMRF) announced on Wednesday that it received a five-year, $14.5 million grant from the National Institutes of Health (NIH) to continue its research on anthrax.
Read More »